Digital Breast Tomosynthesis (DBT) is an exciting new application of digital mammography recently approved by the FDA. DBT is a three-dimensional technology that provides thin cross sectional images through the breast. This technology is designed to prevent overlying structures from obscuring breast masses and intersecting normal structures from being falsely identified as a cancer. There is a growing demand for implementing Digital Breast Tomosynthesis technology at current Women’s Centers as well as understanding how this new technology will impact your current workflow. This webinar will provide you with the tools you will need to understand the fundamentals, benefits and the daily utilization of DBT within your facility. A comprehensive look at the installation and implementation timeline, regulatory guidelines, and additional quality control test and personnel qualifications will also be discussed.
This webinar satisfies the MQSA requirement of 8.0 hours of training in a new mammographic modality specifically on the Hologic, GE, Siemens, and Fujifilm Digital Breast Tomosynthesis Systems.
At the completion of this webinar, attendees should be able to:
Understand the fundamentals of Digital Breast Tomosynthesis (DBT).
Ascertain the benefits of Digital Breast Tomosynthsis over conventional mammography.
Identify additional QC tests for DBT equipment and unique QC tests for each approved unit (Hologic, GE, Siemens and Fujifilm).
Identify personnel training requirements.
Understand the installation and implementation timeline for DBT equipment.
Comprehend Regulatory application processes unique to DBT equipment.
Apply DBT concepts to daily operational needs from an administrative perspective.
Review the Parameter optimization that is unique to Hologic, GE, Siemens and Fujifilm units.
Describe the indications for use and image creation for the Hologic, GE, Siemen and Fujifilm Tomosynthesis units.